{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-032491","form_type":"8-K","ticker":"CATX","cik":"0000728387","company_name":"Perspective Therapeutics, Inc.","filed_at":"2023-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.843180+00:00","generated_at":"2026-06-08T00:36:26.077768+00:00","sec_items":["1.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Perspective Therapeutics establishes $50M ATM equity sales program","bullets":["Entered into at-market issuance agreement with Oppenheimer, B. Riley, and JonesTrading on Nov 17, 2023.","May offer and sell up to $50,000,000 of common stock from time to time at the market.","Agents receive 3.0% commission on gross proceeds from sales effectuated through them.","Program is under a new S-3 registration statement (File No. 333-275638) filed with the SEC."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-032491","json":"https://secwatch.observer/filing/0001437749-23-032491.json","markdown":"https://secwatch.observer/filing/0001437749-23-032491.md","text":"https://secwatch.observer/filing/0001437749-23-032491.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/728387/000143774923032491/0001437749-23-032491-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/728387/000143774923032491/isr20231117_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T00:36:26.077768+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7d01ab998825d94aa13adbbbfc55b135e6369c42","claim":"Perspective Therapeutics, Inc. entered into At Market Issuance Sales Agreement with Oppenheimer & Co. Inc., B. Riley Securities, Inc. and JonesTrading Institutional Services LLC valued at $50,000,000 (effective 2023-11-17).","evidence_excerpt":"On November 17, 2023, Perspective Therapeutics, Inc. (the “Company”) entered into an At Market Issuance Sales Agreement (the “Agreement”) with Oppenheimer & Co. Inc., B. Riley Securities, Inc. and JonesTrading Institutional Services LLC (each, an “Agent” and together, the “Agents”) to create an “at-the-market” equity program under which the Company from time to time may offer and sell shares (the “ATM Shares”) of its common stock, par value $0.001 per share (“Company Common Stock”), through or to the Agents.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923032491/0001437749-23-032491-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Oppenheimer & Co. Inc., B. Riley Securities, Inc. and JonesTrading Institutional Services LLC"},{"label":"Value","value":"$50,000,000"},{"label":"Effective","value":"2023-11-17"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}